Mariska van den Berg
Mariska van den Berg
1Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands
2Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
1,2,
Susan Nijboer‐Brinksma
Susan Nijboer‐Brinksma
1Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands
2Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
1,2,
Sophie Bos
Sophie Bos
1Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands
2Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
1,2,
Maarten van den Berge
Maarten van den Berge
2Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
3Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2,3,
David Lamb
David Lamb
4Immunology and Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany
4,
Martijn van Faassen
Martijn van Faassen
5Department of Laboratory Medicine, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
5,
Ido Kema
Ido Kema
5Department of Laboratory Medicine, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
5,
Reinoud Gosens
Reinoud Gosens
1Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands
2Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
1,2,
Loes Kistemaker
Loes Kistemaker
1Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands
2Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
1,2,✉
1Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands
2Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
3Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
4Immunology and Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany
5Department of Laboratory Medicine, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
*Correspondence,
Loes Kistemaker, Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center, Groningen, The Netherlands.
Email: l.e.m.kistemaker@rug.nl
Received 2019 Oct 30; Revised 2020 Apr 14; Accepted 2020 May 7; Issue date 2020 Oct.
© 2020 The British Pharmacological Society
Open access.
